DCF — CAROLINAS MEDICAL CENTER
Enterprise Value: $-2.9B
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-2.9B
Enterprise Value
$-955.0M
PV of Cash Flows
$-1.9B
PV of Terminal Value
$-3.1B
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $3.1B | $-155.1M | -5.0% | $-287.2M | $-261.1M |
| Year 2 | $3.2B | $-127.6M | -4.0% | $-263.7M | $-217.9M |
| Year 3 | $3.3B | $-98.4M | -3.0% | $-238.5M | $-179.2M |
| Year 4 | $3.4B | $-84.3M | -2.0% | $-228.6M | $-156.1M |
| Year 5 | $3.5B | $-78.0M | -2.0% | $-226.7M | $-140.7M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-2.9B. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$3.0B
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.054717542908487425
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5